Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-010505

Director sold 2,434 shares at an average $295.22 ($718,574)

  • Director acquired 12,278 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SHERWIN STEPHEN A Director 2020-03-11 Option exercise +10,923 $58.46 $638,559 16,517 D: show line 1 in the form
SHERWIN STEPHEN A Director 2020-03-11 Sale −2,164 $295.22 $638,845 14,353 D: show line 2 in the form
SHERWIN STEPHEN A Director 2020-03-11 Option exercise +1,355 $58.46 $79,213 15,708 D: show line 3 in the form
SHERWIN STEPHEN A Director 2020-03-11 Sale −270 $295.29 $79,728 15,438 D: show line 4 in the form
Open-market sales · 2,434 sh · avg $295.22 · $718,574

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SHERWIN STEPHEN A Director 2020-03-11 Option exercise · Stock Option (Right to Buy) −10,923 0 D: show line 5 in the form
SHERWIN STEPHEN A Director 2020-03-11 Option exercise · Stock Option (Right to Buy) −1,355 0 D: show line 6 in the form
Loading xslF345X03/form4.xml…